What is Maestro-03 MBP8298-SP?

Category: Others

false

Phase III double-blind, placebo controlled multi-center study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis.

Side effects

Side effects as an overall problem

Side effects of Maestro-03 MBP8298-SP

Severe
0
Moderate
0
Mild
0
None
1

Dosages

Why Patients Stopped Using Maestro-03 MBP8298-SP (multiple reasons could be selected)
Reason
Personal research
Patients
1
See all 1 patient who’ve stopped using Maestro-03 MBP8298-SP

Duration

Stopped Using Maestro-03 MBP8298-SP
Duration
Patients
Duration
0-1 month
Patients
0
Duration
1-3 months
Patients
0
Duration
3-6 months
Patients
0
Duration
6 months-1 year
Patients
0
Duration
1-2 years
Patients
1
Duration
2 years or more
Patients
0

Adherence


Always
Patients
1
100%
Usually
Patients
0
0%
Sometimes
Patients
0
0%
Never
Patients
0
0%

Burden


Very
Patients
0
0%
Somewhat
Patients
0
0%
A little
Patients
0
0%
Not at all
Patients
1
100%

Cost per month


Cost per month
$200+
Patients
0
0%
Cost per month
$100-199
Patients
0
0%
Cost per month
$50-99
Patients
0
0%
Cost per month
$25-49
Patients
0
0%
Cost per month
< $25
Patients
0
0%
Cost per month
Not specified
Patients
1
100%
Last updated:

1 patient evaluation for Maestro-03 MBP8298-SP

galderson
27923 thumb
galderson
Sex: M
Data Quality: 0 stars
Sensation: Moderate
Overall: Moderate
Cognition: moderate
Vision: mild
Speech: mild
Swallowing: moderate
Upper limb: moderate
Walking: moderate
I have:
MS

See galderson's full Maestro-03 MBP8298-SP history

Jun 9, 2009 (Started Jun 03, 2008)

  • Perceived effectiveness for Other: Can’t tell
  • Side Effects: None
  • Adherence: Always
  • Burden: Not at all
Dosage: 2 other Yearly
Advice & Tips: This was a phase III study and was stopped because it did not show any major improvement.
Cost: Not specified monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Maestro-03 MBP8298-SP